Erschienen in:
25.01.2024 | Case Report - Complication
Remarkable remission of symptomatic dermatomyositis after curative breast cancer surgery
verfasst von:
Makoto Fujino, Masahiro Kawashima, Hajime Yoshifuji, Ran Nakashima, Yosuke Yamada, Yoshiaki Matsumoto, Nobuko Kawaguchi-Sakita, Yukiko Mori, Fengling Pu, Ayane Yamaguchi, Kosuke Kawaguchi, Masahiro Takada, Masakazu Toi
Erschienen in:
International Cancer Conference Journal
|
Ausgabe 2/2024
Einloggen, um Zugang zu erhalten
Abstract
Dermatomyositis (DM) is an autoimmune disease that causes proximal muscle weakness in the extremities leading to severe immobility and dysphagia. Approximately 20% of patients with DM are positive for anti-TIF-1γ antibody and frequently accompanied by malignant tumors. Although DM remission after tumor resection has been reported, the indications for surgery in patients with severe DM are unknown. Herein, we report a case of a 79-year-old Japanese woman who presented with breast cancer and anti-TIF-1γ antibody-positive DM. She became bedridden shortly after DM onset. Although pulsed steroid therapy, intravenous immunoglobulin, tacrolimus, and endocrine therapy with fulvestrant did not improve her symptoms, tumor resection with axillary lymph node dissection resulted in complete remission of the DM after 8 months. Immunohistochemistry revealed high expression of TIF-1γ in cancer cells, both in the primary tumor and axillary lymph nodes. Since the serum levels of anti-TIF-1γ antibody decreased after the surgery, the existence of breast cancer with TIF-1γ expression may have contributed to the worsening of DM. The present case suggests that curative surgery should be considered as a treatment option even if the patient has severe symptoms, such as immobility and dysphagia. Careful discussions with patients and multidisciplinary collaboration are essential to make surgery feasible, particularly for those with severe symptomatic DM.